Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool

Treosulfan is increasingly used as myeloablative agent in conditioning regimen prior to allogeneic hematopoietic stem cell transplantation (HSCT). In our pediatric HSCT program, myalgia was regularly observed after treosulfan-based conditioning, which is a relatively unknown side effect. Using a nat...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Stoep, M. Y. Eileen C., Berghuis, Dagmar, Bredius, Robbert G. M., Buddingh, Emilie P., Mohseny, Alexander B., Smiers, Frans J. W., Guchelaar, Henk-Jan, Lankester, Arjan C., Zwaveling, Juliette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476488/
https://www.ncbi.nlm.nih.gov/pubmed/34580398
http://dx.doi.org/10.1038/s41598-021-98669-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476488/
https://www.ncbi.nlm.nih.gov/pubmed/34580398
http://dx.doi.org/10.1038/s41598-021-98669-3

Ejemplares similares